Making Transporter Models for Drug-Drug Interaction Prediction Mobile

被引:9
|
作者
Ekins, Sean [1 ,2 ]
Clark, Alex M. [3 ]
Wright, Stephen H. [4 ]
机构
[1] Collaborat Pharmaceut Inc, 5616 Hilltop Needmore Rd, Fuquay Varina, NC 27526 USA
[2] Collaborat Drug Discovery, Burlingame, CA USA
[3] Mol Mat Informat Inc, Montreal, PQ, Canada
[4] Univ Arizona, Dept Physiol, Tucson, AZ USA
基金
美国国家卫生研究院;
关键词
TB MOBILE; INHIBITORS; CHEMISTRY; DISCOVERY; DATABASE; PHARMACOPHORE; MULTIDRUG; LIBRARY; MATE1; TOOLS;
D O I
10.1124/dmd.115.064956
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The past decade has seen increased numbers of studies publishing ligand-based computational models for drug transporters. Although they generally use small experimental data sets, these models can provide insights into structure-activity relationships for the transporter. In addition, such models have helped to identify new compounds as substrates or inhibitors of transporters of interest. We recently proposed that many transporters are promiscuous and may require profiling of new chemical entities against multiple substrates for a specific transporter. Furthermore, it should be noted that virtually all of the published ligand-based transporter models are only accessible to those involved in creating them and, consequently, are rarely shared effectively. One way to surmount this is to make models shareable or more accessible. The development of mobile apps that can access such models is highlighted here. These apps can be used to predict ligand interactions with transporters using Bayesian algorithms. We used recently published transporter data sets (MATE1, MATE2K, OCT2, OCTN2, ASBT, and NTCP) to build preliminary models in a commercial tool and in open software that can deliver the model in a mobile app. In addition, several transporter data sets extracted from the ChEMBL database were used to illustrate how such public data and models can be shared. Predicting drug-drug interactions for various transporters using computational models is potentially within reach of anyone with an iPhone or iPad. Such tools could help prioritize which substrates should be used for in vivo drug-drug interaction testing and enable open sharing of models.
引用
收藏
页码:1642 / 1645
页数:4
相关论文
共 50 条
  • [21] Comparison of metabolism and transporter models for predicting gemfibrozil drug-drug interactions
    Gibbons, Laura K.
    Galetin, Aleksandra
    Houston, J. Brian
    DRUG METABOLISM REVIEWS, 2006, 38 : 25 - 26
  • [22] Comparison of metabolism and transporter models for predicting gemfibrozil drug-drug interactions
    Gibbons, Laura K.
    Galetin, Aleksandra
    Houston, J. Brian
    DRUG METABOLISM REVIEWS, 2006, 38 : 77 - 78
  • [23] Multiple inhibition mechanisms and prediction of drug-drug interactions: Status of metabolism and transporter models as exemplified by gemfibrozil-drug interactions
    Hinton, Laura K.
    Galetin, Aleksandra
    Houston, J. Brian
    PHARMACEUTICAL RESEARCH, 2008, 25 (05) : 1063 - 1074
  • [24] Utilizing Drug-Drug Interaction Prediction Tools during Drug Development: Enhanced Decision Making Based on Clinical Risk
    Shardlow, Carole E.
    Generaux, Grant T.
    MacLauchlin, Christopher C.
    Pons, Nicoletta
    Skordos, Konstantine W.
    Bloomer, Jackie C.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (11) : 2076 - 2084
  • [25] Atomoxetine hydrochloride: Clinical drug-drug interaction prediction and outcome
    Sauer, JM
    Long, AJ
    Ring, B
    Gillespie, JS
    Sanburn, NP
    DeSante, KA
    Petullo, D
    VandenBranden, MR
    Jensen, CB
    Wrighton, SA
    Smith, BP
    Read, HA
    Witcher, JW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02): : 410 - 418
  • [26] Leveraging genetic interactions for adverse drug-drug interaction prediction
    Qian, Sheng
    Liang, Siqi
    Yu, Haiyuan
    PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (05)
  • [27] Manifold regularized matrix factorization for drug-drug interaction prediction
    Zhang, Wen
    Chen, Yanlin
    Li, Dingfang
    Yue, Xiang
    JOURNAL OF BIOMEDICAL INFORMATICS, 2018, 88 : 90 - 97
  • [28] Drug-Drug Interaction Prediction on a Biomedical Literature Knowledge Graph
    Bougiatiotis, Konstantinos
    Aisopos, Fotis
    Nentidis, Anastasios
    Krithara, Anastasia
    Paliouras, Georgios
    ARTIFICIAL INTELLIGENCE IN MEDICINE (AIME 2020), 2020, : 122 - 132
  • [29] DMFDDI: deep multimodal fusion for drug-drug interaction prediction
    Gan, Yanglan
    Liu, Wenxiao
    Xu, Guangwei
    Yan, Cairong
    Zou, Guobing
    BRIEFINGS IN BIOINFORMATICS, 2023, 24 (06)
  • [30] Deep learning for drug-drug interaction prediction:A comprehensive review
    Xinyue Li
    Zhankun Xiong
    Wen Zhang
    Shichao Liu
    Quantitative Biology, 2024, 12 (01) : 30 - 52